The responsiveness to these chemicals did not extend to PRIMA-1 which has been reported to restore apoptotic activity of specific tumor-associated p53 missense mutants in engineered cancer cells [34], [35], [36]. The gene discussed is PRIMA1; the disease is neoplasm.